Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach

Bibliographic Details
Main Authors: Alana Deutsch, MD, Natalia Rodriguez, BA, Simon Roy, MD, Jonathan S. Leventhal, MD
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S235251262300067X
_version_ 1797860199117094912
author Alana Deutsch, MD
Natalia Rodriguez, BA
Simon Roy, MD
Jonathan S. Leventhal, MD
author_facet Alana Deutsch, MD
Natalia Rodriguez, BA
Simon Roy, MD
Jonathan S. Leventhal, MD
author_sort Alana Deutsch, MD
collection DOAJ
first_indexed 2024-04-09T21:41:54Z
format Article
id doaj.art-14b3e05c4ae44302badacb11f4569ede
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-04-09T21:41:54Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-14b3e05c4ae44302badacb11f4569ede2023-03-26T05:17:05ZengElsevierJAAD Case Reports2352-51262023-04-01347073Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approachAlana Deutsch, MD0Natalia Rodriguez, BA1Simon Roy, MD2Jonathan S. Leventhal, MD3Department of Dermatology, Yale New Haven Hospital, New Haven, ConnecticutDepartment of Dermatology, Pennsylvania University Hospital, Pennsylvania, PennsylvaniaDivision of Dermatopathology, Department of Dermatology, Yale New Haven Hospital, New Haven, ConnecticutDepartment of Dermatology, Yale New Haven Hospital, New Haven, Connecticut; Correspondence to: Jonathan S. Leventhal, MD, Department of Dermatology, Yale New Haven Hospital, 15 York Street, LMP 5040, New Haven, CT 06510.http://www.sciencedirect.com/science/article/pii/S235251262300067Xerythema multiformejanus kinase inhibitormedical dermatologyoncodermatologypersistent erythema multiformeupadacitinib
spellingShingle Alana Deutsch, MD
Natalia Rodriguez, BA
Simon Roy, MD
Jonathan S. Leventhal, MD
Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
JAAD Case Reports
erythema multiforme
janus kinase inhibitor
medical dermatology
oncodermatology
persistent erythema multiforme
upadacitinib
title Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
title_full Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
title_fullStr Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
title_full_unstemmed Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
title_short Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach
title_sort treatment of persistent erythema multiforme with upadacitinib a novel therapeutic approach
topic erythema multiforme
janus kinase inhibitor
medical dermatology
oncodermatology
persistent erythema multiforme
upadacitinib
url http://www.sciencedirect.com/science/article/pii/S235251262300067X
work_keys_str_mv AT alanadeutschmd treatmentofpersistenterythemamultiformewithupadacitinibanoveltherapeuticapproach
AT nataliarodriguezba treatmentofpersistenterythemamultiformewithupadacitinibanoveltherapeuticapproach
AT simonroymd treatmentofpersistenterythemamultiformewithupadacitinibanoveltherapeuticapproach
AT jonathansleventhalmd treatmentofpersistenterythemamultiformewithupadacitinibanoveltherapeuticapproach